H.R. 4005 · 118th Congress (2023–2025)
Naloxone Affordability Act of 2023
This bill requires the Government Accountability Office to study access to and affordability of naloxone (a medication that temporarily reverses opioid overdoses). The study must address matters related to out-of-pocket costs that consumers pay for naloxone and coverage for naloxone as an over-the-counter drug through Medicare, Medicaid, and private health insurance.
Historically, naloxone required a prescription and so was typically covered by health insurance. However, the Food and Drug Administration approved Narcan (a naloxone hydrochloride nasal spray) for use without a prescription on March 29, 2023, and health insurance does not generally cover over-the-counter medications.
Show official title
To direct the Comptroller General of the United States to conduct a study on naloxone access.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 4005’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Ann M. Kuster (D-NH-2)
- Cosponsors
2 cosponsors
2 original · 0 later
- Rep. Lisa Blunt Rochester (D-DE)· Original · Jun 12, 2023
- Rep. Angie Craig (D-MN-2)· Original · Jun 12, 2023
- Policy area
- Health
- Subjects
- Congressional oversight
- Drug therapy
- Drug, alcohol, tobacco use
- Government studies and investigations
- Health care costs and insurance
- Health care coverage and access
- Medicaid
- Medicare
1 more
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jun 12, 2023 – Jun 16, 2023
Referred to committee
Referred to the House Committee on Energy and Commerce.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Naloxone Affordability Act of 2023
Display title, Short title · Introduced in House
To direct the Comptroller General of the United States to conduct a study on naloxone access.
Official title · Introduced in House